Researchers Hopes to Stop Chicken Pox Vaccine Plan
Merck & Co seeks FDA permission to use a Japanese virus to create a chicken pox vaccine. The company expects approval in about a year and plans immunization for 15 month old children, with later adult vaccines possible. The illness affects most youths by age 10 and can cause serious complications such as pneumonia and encephalitis.
MENTIONED IN THIS ARTICLE
Los Angeles
Merck & Co
Merck
Federal Drug Administration
Roy Walker
Also Mentioned on This Page
By Terry Young
Los Angeles Daily News
Walker
America
Peter Patriarca
Centers For Disease Centrol
Atlanta
CDX
Patriarca
Slumber World
Amherst Plaza
Cooper Foster Park Rd
Saxony
Bigelow
Congoleum
Sun
MasterCard
Visa
Teraran
Elyria
Lorain
Midway
Zoyre
Belgium
Dupont Cirered Stainmaster
Dupont
Rosin
N. Olmsted
Lorain Rd
Great Northern Mail
Sandusky
E. Perkins Ave
Perkins Plaza